Nilotinib
641571-10-0
1- 尼罗替尼
- Nilotinib
- 641571-10-0
For Human Use
- 产品详情-Products Details
Nilotinib is a novel drug for targeted cancer therapy and belongs to tyrosine kinase inhibitors for the treatment of patients of chronic myelogenous leukemia (CML) which is resistant to the Gleevec (imatinib) with an excellent efficacy.
